A detailed history of Squarepoint Ops LLC transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Squarepoint Ops LLC holds 75,392 shares of ADCT stock, worth $150,030. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75,392
Holding current value
$150,030
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.59 - $4.01 $195,265 - $302,321
75,392 New
75,392 $237,000
Q2 2023

Aug 14, 2023

SELL
$1.9 - $2.66 $113,821 - $159,349
-59,906 Reduced 57.3%
44,641 $95,000
Q1 2023

May 15, 2023

BUY
$1.92 - $5.45 $200,730 - $569,781
104,547 New
104,547 $203,000
Q2 2022

Aug 15, 2022

BUY
$5.96 - $14.99 $65,643 - $165,099
11,014 New
11,014 $88,000

Others Institutions Holding ADCT

About ADC Therapeutics SA


  • Ticker ADCT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,645,296
  • Market Cap $155M
  • Description
  • ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...
More about ADCT
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.